AYTU Aytu BioPharma, Inc. - Common Stock
AYTU لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
AYTU مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
AYTU توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 2 22,2%
- شراء 6 66,7%
- احتفاظ 1 11,1%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
3 محللين · 2026-08-17سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 سبتمبر، 2026 | $-0.53 | $-0.33 | — |
| 31 مارس، 2026 | $-0.53 | $-0.52 | -0.01% |
| 31 ديسمبر، 2025 | $-1.05 | $-0.61 | -0.44% |
| 30 سبتمبر، 2025 | $0.21 | $-0.23 | 0.44% |
| 30 يونيو، 2025 | $-2.92 | $-0.04 | -2.9% |
| 31 مارس، 2025 | $0.21 | $-0.17 | 0.38% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| AYTU | $20M | -3.0 | 1.8% | -20.4% | -54.5% | 69.0% |
| MIRA | $63M | -1.1 | -40.3% | -10557.5% | -190.5% | — |
| TXMD | $19M | -32.6 | 71.6% | -18.8% | -2.1% | — |
| QCLS | — | -0.5 | — | — | — | — |
| CTXR | — | -0.4 | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 17
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $66M | $65M | $107M | $97M | $66M | $28M | $7M | $4M | $3M | $3M | $261.8K | · | |
| Cost of Revenue | $21M | $16M | $41M | $44M | $36M | $8M | $2M | $2M | $1M | $957.1K | $88.1K | · | |
| Gross Profit | $46M | $49M | $67M | $52M | $29M | $19M | · | · | · | · | · | · | |
| R&D Expense | $1M | $3M | $4M | $13M | $6M | $2M | $589.1K | $167.6K | $959.9K | $6M | $3M | · | |
| SG&A Expense | $17M | $20M | $29M | $31M | $26M | $20M | $19M | $18M | $17M | $9M | $4M | · | |
| Operating Expenses | $54M | $51M | $84M | $162M | $88M | $40M | $24M | $23M | $23M | $24M | $8M | · | |
| Operating Income | $-8M | $-2M | $-17M | $-110M | $-59M | $-21M | $-17M | $-20M | $-20M | $-22M | $-8M | · | |
| Interest Expense | · | · | · | · | · | $3M | $535.5K | $749.4K | $3M | $5M | $115.0K | · | |
| Other Non-op | $-512.0K | $870.0K | $184.0K | $-757.0K | $-2M | $-3M | $-10M | $4M | $-2M | $-6M | $-115.0K | · | |
| Pretax Income | $-14M | $-10M | $-17M | $-109M | $-58M | $-14M | · | · | · | $-28M | $-8M | · | |
| Income Tax | $437.0K | $2M | $0 | $-110.0K | $259.0K | $0 | $0 | $0 | · | $0 | $-23.9K | · | |
| Net Income | $-14M | $-16M | $-17M | $-109M | $-58M | $-14M | $-27M | $-10M | $-23M | $-28M | $-8M | $-61.7K | |
| EPS (Basic) | $-2.16 | $-2.86 | $-5.11 | $-74.01 | $-3.48 | · | · | · | · | · | · | · | |
| EPS (Diluted) | · | · | $-5.11 | $-74.01 | $-3.48 | · | · | · | · | · | · | · | |
| Shares (Basic) | 6,279,744 | 5,537,957 | 3,339,906 | 1,469,875 | 16,746,679 | · | · | · | · | · | · | · | |
| Shares (Diluted) | · | · | 3,339,906 | 1,469,875 | 16,746,679 | · | · | · | · | · | · | · | |
| EBITDA | $-2M | $3M | $-8M | $-101M | · | $-15M | $-14M | $-17M | · | $-21M | $-8M | · |
الميزانية العمومية 30
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $31M | $20M | $23M | $19M | $50M | $48M | $11M | $7M | $802.3K | $8M | $7M | $2.3K | |
| Short-term Investments | · | · | · | · | · | · | · | · | $0 | $1M | $0 | · | |
| Receivables | $31M | $24M | $29M | $22M | $28M | $6M | $2M | $578.8K | $528.0K | $162.4K | $157.1K | · | |
| Inventory | $11M | $12M | $12M | $11M | $16M | $10M | $1M | $1M | $1M | $524.7K | $39.4K | · | |
| Prepaid Expense | $6M | $5M | $7M | $7M | $10M | $6M | $957.8K | $440.0K | $310.8K | $215.6K | $370.9K | $171 | |
| Other Current Assets | · | $62M | $71M | $633.0K | $1M | $6M | $0 | · | · | · | · | · | |
| Current Assets | $79M | $62M | $73M | $60M | $105M | $75M | $15M | $9M | $3M | $10M | $8M | $2.5K | |
| PP&E (Net) | $532.0K | $693.0K | $2M | · | · | $258.5K | $203.7K | $218.7K | $647.3K | $231.4K | $29.7K | $2.7K | |
| PP&E (Gross) | $1M | $3M | $5M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $714.0K | $2M | $4M | · | · | $484.0K | $396.0K | $540.0K | $246.0K | $112.0K | $60.0K | · | |
| Goodwill | · | · | $0 | $0 | $66M | $28M | $0 | · | $238.4K | $221.0K | $74.0K | · | |
| Intangibles | $42M | $52M | $59M | $71M | $85M | $49M | $49M | $245.9K | $271.3K | $296.6K | $628.8K | · | |
| Other Non-current Assets | $1M | $2M | $3M | $766.0K | $465.0K | $33.0K | $19M | $11M | $9M | $11M | $0 | · | |
| Total Assets | $124M | $118M | $136M | $138M | $266M | $153M | $35M | $21M | $15M | $24M | $18M | $5.5K | |
| Accounts Payable | $11M | $10M | $13M | · | $19M | $12M | $2M | $2M | $2M | $2M | $1M | $310 | |
| Accrued Liabilities | $38M | $38M | $47M | $44M | $57M | $9M | $1M | $185.9K | $782.5K | $1M | · | $1.6K | |
| Short-term Debt | · | $2M | $2M | $4M | · | $982.1K | $0 | · | · | · | · | · | |
| Current Liabilities | $63M | $62M | $69M | $64M | $109M | $29M | $5M | $3M | $4M | $10M | $1M | $50.5K | |
| Capital Leases | $985.0K | $577.0K | $832.0K | $2M | $3M | $725.0K | $0 | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $41.4K | · | |
| Other Non-current Liabilities | $5M | $5M | $7M | $13M | $18M | $11.0K | $0 | · | · | · | · | · | |
| Total Liabilities | · | · | $97M | $93M | $128M | $58M | $28M | $8M | $11M | $14M | $3M | · | |
| Long-term Debt | $13M | $13M | $15M | $15M | · | · | $0 | $0 | · | · | · | · | |
| Total Debt | $13M | $15M | $2M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $4.0K | $3.0K | $1.0K | $1.8K | $179 | $4 | $19 | $119 | $539.7K | |
| Paid-in Capital | $352M | $348M | $343M | · | $316M | $215M | $113M | $93M | $73M | · | · | · | |
| Retained Earnings | $-334M | $-320M | $-304M | $-287M | $-178M | $-120M | $-106M | $-79M | $-69M | $-47M | $-18M | $-630.4K | |
| Stockholders' Equity | $19M | $28M | $39M | $44M | $138M | $95M | $7M | $13M | $4M | $10M | $16M | $-45.0K | |
| Liabilities + Equity | $124M | $118M | $136M | $138M | $266M | $153M | $35M | $21M | $15M | $24M | $18M | $5.5K | |
| Shares Outstanding | 8,976,913 | 5,972,638 | 5,517,174 | 1,928,941 | 27,490,412 | 12,583,736 | 17,538,071 | 1,794,762 | 41,244 | 187,098 | 1,188,307 | 5,735,402 |
التدفق النقدي 18
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $7M | $9M | $10M | $9M | $6M | $3M | $3M | $4M | $874.8K | $118.2K | · | |
| Stock-based Comp | $576.0K | $2M | $6M | $5M | $4M | $1M | $1M | $596.9K | $3M | $902.9K | $1M | · | |
| Deferred Tax | · | $0 | $-126.0K | $-117.0K | $243.0K | · | · | · | · | $0 | $-23.9K | · | |
| Amort. of Intangibles | $4M | $4M | $5M | $6M | $6M | $4M | $2M | $2M | $2M | $664.7K | $90.7K | · | |
| Restructuring | $2M | $2M | $0 | $0 | $5M | $667.0K | · | · | $1.5K | $0 | · | · | |
| Other Non-cash | $6M | $3M | $-3M | $66M | · | $-22M | $10M | $-9M | · | $16M | $-23.0K | · | |
| Operating Cash Flow | $-2M | $-1M | $-5M | $-29M | $-26M | $-28M | $-14M | $-16M | $-14M | $-11M | $-7M | · | |
| CapEx | $228.0K | $329.0K | · | $0 | $2M | $0 | $59.8K | $74.7K | $111.6K | $252.9K | $0 | · | |
| Investing Cash Flow | $-3M | $-329.0K | $-117.0K | $-3M | $-3M | $-6M | $-1M | $-484.3K | $-4M | · | · | · | |
| Debt Issued | $2M | $13M | · | · | · | $640.0K | $0 | $0 | · | · | · | · | |
| Net Debt Issued | $0 | $-16M | · | · | · | $640.0K | $5M | · | · | · | · | · | |
| Stock Issued | · | · | $16M | $12M | $45M | $66M | · | · | $739.9K | $0 | $0 | · | |
| Net Stock Activity | · | · | $16M | · | · | · | · | · | · | $8M | · | · | |
| Financing Cash Flow | $15M | $-1M | $9M | $2M | $30M | $71M | $19M | $23M | $10M | · | · | · | |
| Net Change in Cash | $11M | $-3M | $4M | $-31M | $2M | $37M | $4M | $6M | $-7M | $701.1K | $5M | · | |
| Taxes Paid | $1M | $2M | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-2M | · | · | $-29M | · | $-28M | $-14M | $-16M | · | $-11M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-16M | · | · |
الربحية 8
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.0% | 67.4% | 62.0% | 54.1% | · | · | · | · | · | · | · | · | |
| Operating Margin | -11.8% | -6.5% | -15.9% | -115.4% | · | -76.5% | -230.1% | -538.2% | · | -847.0% | -2915.5% | · | |
| Net Margin | -20.4% | -19.6% | -15.9% | -114.0% | · | -49.3% | -370.6% | -278.4% | · | -1099.7% | -2950.3% | · | |
| Pretax Margin | -20.7% | -17.4% | -15.9% | -114.1% | · | · | · | · | · | -1099.7% | -2959.4% | · | |
| EBITDA Margin | -3.7% | 3.7% | -7.7% | -104.8% | · | -53.9% | -192.9% | -467.4% | · | -812.9% | -2870.4% | · | |
| ROA | -11.2% | -12.4% | -12.4% | -54.6% | · | -14.5% | -97.3% | -56.5% | · | -132.5% | -84.7% | · | |
| ROE | -54.5% | -54.2% | -42.5% | -145.3% | · | -15.1% | -234.6% | -77.8% | · | -219.3% | -99.2% | · | |
| ROIC | -25.5% | -13.8% | -41.7% | -241.8% | · | · | · | · | · | -215.2% | -48.7% | · |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | · | 1.1 | 0.9 | · | 2.6 | 2.9 | 2.8 | · | 1.0 | 5.5 | · | |
| Quick Ratio | 1.0 | 0.7 | 0.8 | 0.6 | · | 1.9 | 2.4 | 2.2 | · | 0.9 | 5.1 | · | |
| Debt / Equity | 0.7 | 0.5 | 0.0 | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.4 | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | -8.1 | -31.5 | -26.3 | · | -4.0 | · | · |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.8 | 0.5 | · | 0.3 | 0.3 | 0.2 | · | 0.1 | 0.0 | · | |
| Inventory Turnover | 1.7 | 2.1 | 3.6 | 3.3 | · | 1.3 | 1.6 | 1.5 | · | 3.4 | 4.5 | · | |
| Receivables Turnover | 2.4 | 3.1 | 4.2 | 3.9 | · | 8.0 | 6.3 | 6.6 | · | 16.0 | 3.3 | · |
معدلات النمو 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 1.8% | -39.3% | 11.1% | 47.3% | 137.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -11.8% | -0.23% | 57.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.2% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $66M | $65M | $107M | $97M | $66M | $28M | $7M | $4M | $3M | $3M | $261.8K | · | |
| Net Income TTM | $-14M | $-16M | $-17M | $-109M | $-58M | $-14M | $-27M | $-10M | $-23M | $-28M | $-8M | $-61.7K | |
| Market Cap | $20M | $17M | $9M | $532M | · | $35.74B | $6.63B | $1.87B | · | $1.40T | $5.20T | · | |
| Enterprise Value | $1M | $13M | $-13M | · | · | · | · | · | · | · | · | · | |
| P/E | -3.0 | -0.7 | -0.3 | -0.2 | -28.8 | · | · | · | · | · | · | · | |
| P/S | 0.3 | 0.3 | 0.1 | 5.5 | · | 1293.3 | 905.6 | 510.0 | · | 546737.1 | 19871235.0 | · | |
| P/B | 1.0 | 0.6 | 0.2 | 11.6 | · | 376.1 | 935.3 | 139.0 | · | 138914.1 | 333105.9 | · | |
| P / Tangible Book | · | · | · | · | · | 1977.7 | · | · | · | · | · | · | |
| P / Cash Flow | -10.1 | -12.6 | -1.7 | -18.5 | · | -1259.5 | -479.3 | -117.1 | · | -131455.8 | -784106.7 | · | |
| P / FCF | -9.0 | · | · | -18.5 | · | -1259.5 | -477.2 | -116.6 | · | -128408.3 | · | · | |
| EV / EBITDA | -0.6 | 4.2 | 1.5 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -0.6 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.0 | 0.2 | -0.1 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -33.0% | -136.0% | -319.4% | -536.3% | -3.5% | · | · | · | · | · | · | · |
قائمة الدخل 16
| المقياس | اتجاه | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12M | $15M | $14M | $15M | $18M | $16M | $17M | $15M | $14M | $19M | $18M | $31M | $23M | $26M | $28M | $27M | |
| Cost of Revenue | $5M | $6M | $5M | $5M | $6M | $5M | $5M | $4M | $4M | $4M | $5M | $12M | $10M | $9M | $10M | $13M | |
| Gross Profit | $8M | $10M | $9M | $10M | $13M | $11M | $12M | $11M | $10M | $15M | $13M | $19M | $13M | $17M | $18M | $15M | |
| R&D Expense | $0 | $0 | $0 | $216.0K | $162.0K | $522.0K | $426.0K | $1M | $611.0K | $521.0K | $595.0K | $465.0K | $856.0K | $2M | $1M | $3M | |
| SG&A Expense | $5M | $5M | $5M | $4M | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $6M | $7M | $8M | $7M | $7M | |
| Operating Expenses | $12M | $12M | $11M | $18M | $10M | $12M | $13M | $13M | $12M | $11M | $14M | $18M | $21M | $24M | $20M | $32M | |
| Operating Income | $-4M | $-2M | $-2M | $-8M | $2M | $-2M | $-930.0K | $-2M | $-2M | $3M | $-867.0K | $169.0K | $-9M | $-7M | $-2M | $-17M | |
| Other Non-op | $149.0K | $190.0K | $201.0K | $-1M | $36.0K | $140.0K | $542.0K | $120.0K | $70.0K | $96.0K | $584.0K | $4M | $-1M | $-1M | $-1M | $-428.0K | |
| Pretax Income | $-6M | $-11M | $2M | $-19M | $4M | $382.0K | $1M | $-3M | $-2M | $1M | $-7M | $-2M | $-7M | $-7M | $-701.0K | $-16M | |
| Income Tax | $10.0K | $0 | $0 | $437.0K | $-122.0K | $-283.0K | $405.0K | $841.0K | $521.0K | $780.0K | $0 | $0 | $0 | $0 | · | $0 | |
| Net Income | $-6M | $-11M | $2M | $-20M | $4M | $788.0K | $1M | $-5M | $-3M | $-220.0K | $-8M | $-2M | $-7M | $-7M | $-701.0K | $-16M | |
| EPS (Basic) | $-0.53 | $-1.05 | $0.21 | $-3.18 | $0.65 | $0.13 | $0.24 | $-0.82 | $-0.52 | $-0.04 | $-1.48 | $-0.75 | $-1.93 | $-2.15 | $-0.28 | $-7.61 | |
| EPS (Diluted) | $-0.53 | $-1.05 | $-0.08 | · | $0.21 | $-0.26 | $-0.15 | · | $-0.52 | $-0.04 | $-1.48 | · | $-1.93 | $-2.15 | $-0.28 | $-7.61 | |
| Shares (Basic) | 10,511,583 | 10,036,359 | 9,441,073 | -12,054,969 | 6,134,634 | 6,132,060 | 6,068,019 | -10,995,305 | 5,533,555 | 5,517,670 | 5,482,037 | -6,015,083 | 3,726,779 | 3,110,304 | 2,517,906 | -2,615,105 | |
| Shares (Diluted) | 10,511,583 | 10,036,359 | 19,476,635 | · | 8,204,453 | 8,485,112 | 9,099,601 | · | 5,533,555 | 5,517,670 | 5,482,037 | · | 3,726,779 | 3,110,304 | 2,517,906 | -2,615,105 | |
| EBITDA | $-4M | $-2M | $-701.0K | · | $2M | $-2M | $-930.0K | · | $-2M | $2M | $726.0K | · | $-9M | $-7M | $675.0K | · |
الميزانية العمومية 28
| المقياس | اتجاه | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $30M | $33M | $31M | $18M | $20M | $20M | $20M | $20M | $20M | $20M | $23M | $19M | $20M | $24M | $19M | |
| Receivables | $24M | $31M | $33M | $31M | $36M | $25M | $23M | $24M | $30M | $29M | $30M | $29M | $34M | $26M | $28M | $22M | |
| Inventory | $7M | $9M | $10M | $11M | $11M | $11M | $12M | $12M | $13M | $13M | $13M | $12M | $14M | $13M | $13M | $11M | |
| Prepaid Expense | $9M | $7M | $5M | $6M | $7M | $6M | $6M | $5M | $7M | $8M | $7M | $7M | $10M | $12M | $9M | $7M | |
| Other Current Assets | · | · | · | · | · | $63M | $61M | · | $1M | $1M | $749.0K | $71M | $1M | $624.0K | $785.0K | $633.0K | |
| Current Assets | $67M | $76M | $81M | $79M | $73M | · | · | $62M | $71M | $71M | $71M | · | $78M | $71M | $74M | $60M | |
| PP&E (Net) | $407.0K | $484.0K | $500.0K | $532.0K | $546.0K | $516.0K | $692.0K | $693.0K | $967.0K | $1M | · | $2M | · | · | · | · | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $1M | $3M | $3M | $4M | $4M | · | $5M | · | · | · | · | |
| Accum. Depreciation | $802.0K | $768.0K | $735.0K | $714.0K | $690.0K | $651.0K | $2M | $2M | $3M | $3M | · | $4M | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $0 | |
| Intangibles | $42M | $44M | $41M | $42M | $49M | $50M | $51M | $52M | $54M | $56M | $57M | $59M | $63M | $65M | $69M | $71M | |
| Other Non-current Assets | $556.0K | $738.0K | $939.0K | $1M | $1M | $2M | $2M | $2M | $889.0K | $907.0K | $772.0K | $3M | $892.0K | $821.0K | $829.0K | $766.0K | |
| Total Assets | $112M | $122M | $125M | $124M | $124M | $116M | $116M | $118M | $129M | $131M | $133M | $136M | $147M | $141M | $150M | $138M | |
| Accounts Payable | $13M | $14M | $12M | $11M | $12M | $12M | $14M | $10M | $10M | $10M | · | $13M | · | · | · | · | |
| Accrued Liabilities | $34M | $40M | $37M | $38M | $42M | $39M | $34M | $38M | $44M | $43M | $41M | $47M | $50M | $41M | $41M | $44M | |
| Short-term Debt | · | · | · | · | · | $4M | $4M | · | $2M | $1M | $1M | $2M | $10M | $7M | · | $4M | |
| Current Liabilities | $60M | $66M | $66M | $63M | $71M | $64M | $61M | $62M | $84M | $64M | $65M | $69M | $85M | $67M | $73M | $64M | |
| Capital Leases | $919.0K | $973.0K | $1M | $985.0K | $1M | $1M | $1M | $577.0K | $783.0K | · | $1M | $832.0K | $1M | $1M | $2M | $2M | |
| Other Non-current Liabilities | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $8M | $7M | $8M | $10M | $9M | $13M | |
| Total Liabilities | · | · | · | · | · | · | · | · | · | · | $101M | · | $106M | $96M | $102M | $93M | |
| Long-term Debt | $11M | $12M | $12M | $13M | $11M | $12M | $12M | · | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | |
| Total Debt | $11M | $12M | $12M | · | $11M | $16M | $17M | · | $17M | $16M | $1M | · | $10M | $7M | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | $6.0K | · | |
| Paid-in Capital | $383M | $356M | $355M | $352M | $349M | $348M | $348M | $348M | $346M | $345M | · | $343M | · | · | · | · | |
| Retained Earnings | $-348M | $-342M | $-332M | $-334M | $-314M | $-318M | $-318M | $-320M | $-315M | $-312M | $-312M | $-304M | $-302M | $-294M | $-288M | $-287M | |
| Stockholders' Equity | $35M | $14M | $23M | $19M | $35M | $31M | $30M | $28M | $31M | $33M | $32M | $39M | $41M | $46M | $48M | $44M | |
| Liabilities + Equity | $112M | $122M | $125M | $124M | $124M | $116M | $116M | $118M | $129M | $131M | $133M | $136M | $147M | $141M | $150M | $138M | |
| Shares Outstanding | 10,733,208 | 10,733,208 | 9,911,913 | 8,976,913 | 6,170,162 | 6,169,681 | 6,149,202 | 5,972,638 | 5,567,909 | 5,567,347 | 5,530,235 | 5,517,174 | 3,779,513 | 3,383,145 | 3,121,471 | 1,928,941 |
التدفق النقدي 14
| المقياس | اتجاه | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $885.0K | $803.0K | $1M | $1M | $1M | $1M | $2M | $758.0K | $1M | $-3M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $148.0K | $283.0K | $114.0K | $113.0K | $139.0K | $151.0K | $173.0K | $-188.0K | $811.0K | $820.0K | $930.0K | $900.0K | $902.0K | $3M | $1M | $1M | |
| Amort. of Intangibles | $761.0K | $526.0K | $444.0K | $921.0K | $920.0K | $921.0K | $921.0K | $921.0K | $920.0K | $918.0K | $924.0K | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | $0 | $0 | $0 | $0 | $0 | $1M | $784.0K | $2M | $244.0K | $0 | $0 | · | · | · | · | · | |
| Other Non-cash | · | · | $-4M | · | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Operating Cash Flow | $-4M | $4M | $-618.0K | $3M | $-6M | $3M | $-1M | $-788.0K | $-300.0K | $-135.0K | $89.0K | $9M | $-3M | $-2M | $-9M | $-7M | |
| CapEx | $0 | $17.0K | $0 | $17.0K | $69.0K | $6.0K | $136.0K | $329.0K | $0 | · | $0 | · | · | · | · | · | |
| Investing Cash Flow | $0 | $-17.0K | $0 | $-3M | $-69.0K | $145.0K | $381.0K | $-34.0K | $-45.0K | $-174.0K | $174.0K | $-155.0K | $1.0K | $-5.0K | $42.0K | $-41.0K | |
| Net Debt Issued | · | · | $-464.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-1M | |
| Financing Cash Flow | $872.0K | $-6M | $2M | $13M | $4M | $-3M | $911.0K | $1M | $530.0K | $-126.0K | $126.0K | $-5M | $3M | $-2M | $14M | $-1M | |
| Net Change in Cash | $-3M | $-3M | $2M | $13M | $-2M | $290.0K | $102.0K | $246.0K | $231.0K | $-435.0K | $435.0K | $4M | $-322.0K | $-4M | $4M | $-8M | |
| Taxes Paid | $0 | $61.0K | $140.0K | $0 | $0 | $973.0K | $446.0K | $1M | $130.0K | · | $-186.0K | $0 | $0 | · | · | · | |
| Free Cash Flow | · | · | $-618.0K | · | · | · | · | · | · | · | · | · | · | · | · | · |
الربحية 8
| المقياس | اتجاه | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.2% | 63.5% | 66.1% | · | 69.4% | 66.5% | 72.3% | · | 65.0% | 70.7% | 66.9% | · | 56.1% | 65.8% | 65.2% | · | |
| Operating Margin | -32.8% | -13.0% | -10.8% | · | 13.1% | -10.4% | -5.6% | · | -13.7% | 10.3% | -6.8% | · | -37.6% | -25.9% | -6.0% | · | |
| Net Margin | -45.3% | -69.8% | 14.1% | · | 21.6% | 4.9% | 8.9% | · | -16.1% | -0.96% | -36.7% | · | -31.7% | -25.5% | · | · | |
| Pretax Margin | -45.2% | -69.8% | 14.1% | · | 20.7% | 2.4% | 9.0% | · | -14.7% | 2.6% | -36.7% | · | -31.7% | -25.5% | -2.5% | · | |
| EBITDA Margin | -32.8% | -13.0% | -5.1% | · | 13.1% | -10.4% | -5.6% | · | -13.7% | 10.3% | 3.3% | · | -37.6% | -25.9% | 2.4% | · | |
| ROA | -4.8% | -8.9% | 1.6% | · | 3.2% | 0.64% | 1.2% | · | -2.1% | -0.16% | -5.7% | · | -4.6% | -3.7% | · | · | |
| ROE | -16.0% | -47.1% | 7.4% | · | 12.2% | 2.5% | 4.8% | · | -8.1% | -0.56% | -20.2% | · | -14.1% | -8.8% | · | · | |
| ROIC | -8.8% | -7.6% | -4.2% | · | 5.4% | -6.3% | -1.5% | · | -5.7% | -1.8% | · | · | · | · | · | · |
السيولة والملاءة 4
| المقياس | اتجاه | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.2 | 1.2 | · | 1.0 | · | · | · | 0.8 | 1.1 | 1.1 | · | 0.9 | 1.1 | 1.0 | · | |
| Quick Ratio | 0.9 | 0.9 | 1.0 | · | 0.8 | 0.7 | 0.7 | · | 0.6 | 0.8 | 0.8 | · | 0.6 | 0.7 | 0.7 | · | |
| Debt / Equity | 0.3 | 0.8 | 0.5 | · | 0.3 | 0.5 | 0.6 | · | 0.5 | 0.5 | 0.0 | · | 0.3 | 0.2 | · | · | |
| LT Debt / Equity | 0.3 | 0.7 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.0 | 0.5 | · | · | · | · | · | · |
الكفاءة 3
| المقياس | اتجاه | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | |
| Inventory Turnover | 0.5 | 0.6 | 0.4 | · | 0.5 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.7 | 0.6 | 0.7 | · | |
| Receivables Turnover | 0.4 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.8 | 0.8 | · | 0.7 | 1.1 | 1.1 | · |
التقييم (آخر 12 شهرًا) 13
| المقياس | اتجاه | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $60M | $64M | $65M | · | $65M | $66M | $67M | · | $73M | $86M | $94M | · | $101M | $101M | $97M | · | |
| Net Income TTM | $-10M | $-4M | $8M | · | $3M | $-845.0K | $-10M | · | $-18M | $-22M | $-23M | · | $-68M | $-72M | $-93M | · | |
| Market Cap | $29M | $28M | $19M | · | $7M | $10M | $14M | · | $17M | $16M | $15M | · | $8M | $13M | $12M | · | |
| Enterprise Value | $14M | $10M | $-2M | · | $623.2K | $6M | $11M | · | $14M | $12M | $-4M | · | $-309.9K | $784.0K | · | · | |
| P/E | -1.9 | -2.2 | -6.7 | · | -1.7 | -1.8 | -1.1 | · | -0.8 | -0.5 | -0.5 | · | -0.1 | -0.1 | -0.1 | · | |
| P/S | 0.5 | 0.4 | 0.3 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | |
| P/B | 0.8 | 2.0 | 0.8 | · | 0.2 | 0.3 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.2 | 0.3 | 0.2 | · | |
| P / Cash Flow | · | · | -30.2 | · | · | · | · | · | · | · | -70.8 | · | · | · | -1.3 | · | |
| P / FCF | · | · | -30.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | -3.4 | -4.9 | 2.4 | · | 0.3 | -3.5 | -11.7 | · | -5.6 | 5.2 | -5.3 | · | 0.0 | -0.1 | · | · | |
| EV / FCF | · | · | 2.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.2 | 0.2 | -0.0 | · | 0.0 | 0.1 | 0.2 | · | 0.2 | 0.1 | -0.0 | · | -0.0 | 0.0 | · | · | |
| Earnings Yield | -53.1% | -45.4% | -14.9% | · | -60.0% | -57.1% | -93.2% | · | -130.6% | -197.2% | -216.3% | · | -1797.3% | -1238.7% | -1754.7% | · |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| الإيرادات | $66M | $65M | $107M | $97M | $66M |
| هامش الربح الإجمالي % | 69.0% | 67.4% | 62.0% | 54.1% | — |
| هامش الربح التشغيلي % | -11.8% | -6.5% | -15.9% | -115.4% | — |
| صافي الدخل | $-14M | $-16M | $-17M | $-109M | $-58M |
| EPS المخفف | — | — | $-5.11 | $-74.01 | $-3.48 |
الميزانية العمومية
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.7 | 0.5 | 0.0 | — | — |
| النسبة الحالية | 1.3 | — | 1.1 | 0.9 | — |
| النسبة السريعة | 1.0 | 0.7 | 0.8 | 0.6 | — |
التدفق النقدي
| 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $-2M | — | — | $-29M | — |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 43 مقدمي إقرار · $8.5M إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 5 (+1 مقابل الربع السابق) | 2 (-1 مقابل الربع السابق) | 11 (+2 مقابل الربع السابق) | 5 (+1 مقابل الربع السابق) | +240K |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | $2336646 | 1086812 | 27,64% | الأسهم |
| Stonepine Capital Management, LLC | $1962780 | 912921 | 23,22% | الأسهم |
| AWM Investment Company, Inc. | $1332084 | 619574 | 15,76% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $561464 | 261146 | 6,64% | الأسهم |
| CROWN ADVISORS MANAGEMENT, INC. | $430000 | 200000 | 5,09% | الأسهم |
| DIADEMA PARTNERS LP | $319374 | 148546 | 3,78% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $226451 | 105326 | 2,68% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $225369 | 104823 | 2,67% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $156742 | 72889 | 1,85% | الأسهم |
| VANGUARD GROUP INC | $122325 | 47048 | 1,45% | الأسهم |
| TWO SIGMA ADVISERS, LP | $110500 | 42500 | 1,31% | الأسهم |
| CITADEL ADVISORS LLC | $106240 | 49414 | 1,26% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $101153 | 47048 | 1,20% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $94579 | 43990 | 1,12% | الأسهم |
| Persistent Asset Partners Ltd | $81666 | 37984 | 0,97% | الأسهم |
| NORTHERN TRUST CORP | $55214 | 25681 | 0,65% | الأسهم |
| BELLEVUE ASSET MANAGEMENT, LLC | $53777 | 25013 | 0,64% | الأسهم |
| PERRITT CAPITAL MANAGEMENT INC | $52000 | 20000 | 0,62% | الأسهم |
| BlackRock, Inc. | $49005 | 22793 | 0,58% | الأسهم |
| XTX Topco Ltd | $46044 | 21416 | 0,54% | الأسهم |
| Daytona Street Capital LLC | $22350 | 10000 | 0,26% | الأسهم |
| Tower Research Capital LLC (TRC) | $4799 | 2232 | 0,06% | الأسهم |
| ROYAL BANK OF CANADA | $1000 | 378 | 0,01% | الأسهم |
| OSAIC HOLDINGS, INC. | $991 | 462 | 0,01% | الأسهم |
| UBS Group AG | $559 | 260 | 0,01% | الأسهم |
| JPMORGAN CHASE & CO | $337 | 154 | 0,00% | الأسهم |
| MORGAN STANLEY | $269 | 125 | 0,00% | الأسهم |
| CIBC Private Wealth Group LLC | $156 | 83 | 0,00% | الأسهم |
| BARCLAYS PLC | $108 | 50 | 0,00% | الأسهم |
| GROUP ONE TRADING LLC | $80 | 37 | 0,00% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $49 | 23 | 0,00% | الأسهم |
| WELLS FARGO & COMPANY/MN | $26 | 12 | 0,00% | الأسهم |
| Rockefeller Capital Management L.P. | $22 | 10 | 0,00% | الأسهم |
| SBI Securities Co., Ltd. | $22 | 10 | 0,00% | الأسهم |
| Moser Wealth Advisors, LLC | $22 | 10 | 0,00% | الأسهم |
| ACADIAN ASSET MANAGEMENT LLC | $22 | 10237 | 0,00% | الأسهم |
| Farther Finance Advisors, LLC | $9 | 4 | 0,00% | الأسهم |
| VISION FINANCIAL MARKETS LLC | $5 | 2 | 0,00% | الأسهم |
| Caitong International Asset Management Co., Ltd | $4 | 2 | 0,00% | الأسهم |
| Arax Advisory Partners | $4 | 2 | 0,00% | الأسهم |
| JONES FINANCIAL COMPANIES LLLP | $2 | 1 | 0,00% | الأسهم |
| FNY Investment Advisers, LLC | $0 | 110 | 0,00% | الأسهم |
| TSFG, LLC | $0 | 1 | 0,00% | الأسهم |
المطلعون على الشركة 16 من المطلعين · مسؤولون 9 · مديرون 7
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Joshua R. Disbrow | Chief Executive Officer | 28 يوليو، 2026 A | 237203 | 0 | 0 | $0 |
| Ryan J Selhorn | Chief Financial Officer | 28 يوليو، 2026 A | 74743 | 0 | 0 | $0 |
| Mark K Oki | Chief Financial Officer | 11 أغسطس، 2023 A | — | 0 | 0 | $0 |
| David A Green | Chief Financial Officer | 21 ديسمبر، 2018 S | 266250 | 0 | 0 | $0 |
| Gregory A Gould | Chief Financial Officer | 2 أغسطس، 2016 A | 206899 | 0 | 0 | $0 |
| Christopher Brooke | Chief Operating Officer | 11 أغسطس، 2023 A | — | 0 | 0 | $0 |
| Greg Pyszczymuka | Chief Commercial Officer | 28 يوليو، 2026 A | 56102 | 0 | 0 | $0 |
| Jarrett Disbrow | Chief Business Officer | 28 يوليو، 2026 A | 76568 | 0 | 0 | $0 |
| Jonathan H Mcgrael | VP of Commercial Operations | 7 يوليو، 2016 A | 140000 | 0 | 0 | $0 |
| Abhinav Jain | مدير | 28 يوليو، 2026 A | 29500 | 0 | 0 | $0 |
| John Donofrio Jr. | مدير | 28 يوليو، 2026 A | 23762 | 0 | 0 | $0 |
| Carl Dockery | مدير | 28 يوليو، 2026 A | 31152 | 0 | 0 | $0 |
| Vivian H Liu | مدير | 28 يوليو، 2026 A | 29825 | 0 | 0 | $0 |
| Gary Cantrell | مدير | 24 أكتوبر، 2018 A | 152840 | 0 | 0 | $0 |
| Michael Macaluso | مدير | 24 أكتوبر، 2018 A | 202738 | 0 | 0 | $0 |
| Ampio Pharmaceuticals, Inc. | مالك 10% | 1 ديسمبر، 2015 J | 1226407 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 3 حيازات
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC, Harkey Wilmot B., Mack Daniel ×4 إيداعات | 9 يونيو، 2025 | 14,40% | تعديل | — | SEC |
| Armistice Capital, LLC, Steven Boyd ×12 إيداعات | 1 سبتمبر، 2021 | — | إيداع أولي | — | SEC |
| AMPIO PHARMACEUTICALS, INC. | 24 إبريل، 2015 | — | إيداع أولي | اندماج واستحواذ / بيع | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 6 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| DFSU · Dimensional ETF Trust | 0,00% | 4805 NS | 30 إبريل، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 2147 NS | 30 إبريل، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 4402 NS | 30 إبريل، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 92146 SH | 8 أغسطس، 2026 | يومي |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 169000 SH | 8 أغسطس، 2026 | يومي |
| DFAC · Dimensional ETF Trust | 0,00% | 4122 NS | 30 إبريل، 2026 | N-PORT |